Analyzing Ducommun (DCO) & Its Peers

Ducommun (NYSE: DCO) is one of 62 publicly-traded companies in the “AEROSPACE/DEFENSE” industry, but how does it weigh in compared to its peers? We will compare Ducommun to similar companies based on the strength of its institutional ownership, risk, valuation, earnings, dividends, analyst recommendations and profitability.

Earnings & Valuation

How to Become a New Pot Stock Millionaire

This table compares Ducommun and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ducommun $558.18 million $20.07 million 16.59
Ducommun Competitors $8.26 billion $580.70 million 21.85

Ducommun’s peers have higher revenue and earnings than Ducommun. Ducommun is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional and Insider Ownership

82.5% of Ducommun shares are owned by institutional investors. Comparatively, 56.3% of shares of all “AEROSPACE/DEFENSE” companies are owned by institutional investors. 8.2% of Ducommun shares are owned by company insiders. Comparatively, 8.7% of shares of all “AEROSPACE/DEFENSE” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Ducommun and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ducommun 3.60% 6.82% 2.75%
Ducommun Competitors -0.95% -265.63% 8.25%

Analyst Ratings

This is a breakdown of recent ratings for Ducommun and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ducommun 0 1 3 0 2.75
Ducommun Competitors 372 2195 2980 101 2.50

Ducommun presently has a consensus price target of $37.00, indicating a potential upside of 28.21%. As a group, “AEROSPACE/DEFENSE” companies have a potential upside of 5.64%. Given Ducommun’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Ducommun is more favorable than its peers.

Risk and Volatility

Ducommun has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500. Comparatively, Ducommun’s peers have a beta of 0.80, indicating that their average share price is 20% less volatile than the S&P 500.

Summary

Ducommun beats its peers on 7 of the 13 factors compared.

About Ducommun

Ducommun Incorporated is a global provider of engineering and manufacturing services for various products and failure applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. The Company is a solution-based provider, offering a range of value-added products and services in its primary businesses of electronics, structures and integrated solutions. The Company operates through two segments: Electronic Systems (ES) and Structural Systems (SS). The ES has over three product offerings in electronics manufacturing for various applications, including complex cable assemblies and interconnect systems, printed circuit board assemblies, and electronic, electromechanical and mechanical assemblies. The SS segment offers over three product offerings to support a customer base, including commercial aircraft, military fixed-wing aircraft, and military and commercial rotary-wing aircraft.

Receive News & Ratings for Ducommun Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ducommun and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

China Life Insurance  versus Its Rivals Head to Head Analysis
China Life Insurance versus Its Rivals Head to Head Analysis
Analysts Expect BeiGene  Will Post Earnings of -$1.96 Per Share
Analysts Expect BeiGene Will Post Earnings of -$1.96 Per Share
Zacks: Analysts Anticipate Clementia Pharmaceuticals  Will Post Earnings of -$0.33 Per Share
Zacks: Analysts Anticipate Clementia Pharmaceuticals Will Post Earnings of -$0.33 Per Share
1347 PIH  Receiving Somewhat Positive Media Coverage, Accern Reports
1347 PIH Receiving Somewhat Positive Media Coverage, Accern Reports
Good Times Burgers & Frozen Custard  Getting Somewhat Favorable Press Coverage, Analysis Finds
Good Times Burgers & Frozen Custard Getting Somewhat Favorable Press Coverage, Analysis Finds
First Community Co. to Issue Quarterly Dividend of $0.10
First Community Co. to Issue Quarterly Dividend of $0.10


© 2006-2018 Ticker Report. Google+.